The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin a intoxication

被引:38
作者
Dickerson, Tobin J.
Janda, Kim D.
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, WIRM, La Jolla, CA 92037 USA
关键词
D O I
10.1021/cb600179d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins ( BoNTs) are agents responsible for botulism, a disease characterized by peripheral neuromuscular blockade and subsequent flaccid paralysis. The potent paralytic ability of these toxins has resulted in their use as a therapeutic; however, BoNTs are also classified by the Centers for Disease Control and Prevention as one of the six highest-risk threat agents of bioterrorism. Consequently, a thorough understanding of the molecular mechanism of BoNT toxicity is crucial before effective inhibitors and, ultimately, an approved drug can be developed. In this article, we systematically detail BoNT intoxication by examining each of the discrete steps in this process. Additionally, rationally designed strategies for combating the toxicity of the most potent BoNT serotype are evaluated.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 75 条
[1]   ANTAGONISM OF BOTULINUM TOXIN-INDUCED MUSCLE WEAKNESS BY 3,4-DIAMINOPYRIDINE IN RAT PHRENIC NERVE-HEMIDIAPHRAGM PREPARATIONS [J].
ADLER, M ;
SCOVILL, J ;
PARKER, G ;
LEBEDA, FJ ;
PIOTROWSKI, J ;
DESHPANDE, SS .
TOXICON, 1995, 33 (04) :527-537
[2]   Antagonism of botulinum toxin A-mediated muscle paralysis by 3,4-diaminopyridine delivered via osmotic minipumps [J].
Adler, M ;
Capacio, B ;
Deshpande, SS .
TOXICON, 2000, 38 (10) :1381-1388
[3]   Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin [J].
Adler, M ;
Macdonald, DA ;
Sellin, LC ;
Parker, GW .
TOXICON, 1996, 34 (02) :237-249
[4]   Protection by the heavy metal chelator N,N,N',N'-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN) against the lethal action of botulinum neurotoxin A and B [J].
Adler, M ;
Dinterman, RE ;
Wannemacher, RW .
TOXICON, 1997, 35 (07) :1089-1100
[5]   Human botulism immune globulin for the treatment of infant botulism [J].
Arnon, SS ;
Schechter, R ;
Maslanka, SE ;
Jewell, NP ;
Hatheway, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :462-471
[6]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[7]   Synaptic vesicle docking and fusion [J].
Bajjalieh, SM .
CURRENT OPINION IN NEUROBIOLOGY, 1999, 9 (03) :321-328
[8]  
BAKRY N, 1991, J PHARMACOL EXP THER, V258, P830
[9]   The synaptic vesicle cycle [J].
Betz, WJ ;
Angleson, JK .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :347-363
[10]   INTERACTION OF I-125 LABELED BOTULINUM NEUROTOXINS WITH NERVE-TERMINALS .1. ULTRASTRUCTURAL AUTORADIOGRAPHIC LOCALIZATION AND QUANTITATION OF DISTINCT MEMBRANE ACCEPTORS FOR TYPE-A AND TYPE-B ON MOTOR NERVES [J].
BLACK, JD ;
DOLLY, JO .
JOURNAL OF CELL BIOLOGY, 1986, 103 (02) :521-534